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Summary. Background: Oral anticoagulant therapy (OAT)
implies frequent blood checks and dose changes to prevent
thromboembolic or hemorrhagic complications. This may
interfere with patients’ social and working circumstances in
addition to the possible stress caused by the condition
necessitating this treatment. We studied whether patient self-
management could be a way to improve quality of life in these
patients. Methods: Within a multicenter randomized study
performed by two Dutch anticoagulation clinics, designed to
study the eﬀect on treatment quality (time within target range)
of diﬀerentmodalities of patient self-management, we looked at
the eﬀect of increased patient education (n ¼ 28), self-monit-
oring of the International Normalized Ratio (INR) (n ¼ 47)
and full patient self-management (INR monitoring and dosing
of the OAT) (n ¼ 41) on the quality of life of the patients. This
was done with the aid of a written questionnaire (32 questions,
minimum score ¼ 1, maximum score ¼ 6) at baseline
(n ¼ 163), and after 26 weeks (n ¼ 118). We compared the
results after 26 weeks with those at baseline, as well as between
groups. Results: General treatment satisfaction was already
high under routine care (5.11 on a scale of 1–6) and increased
further through self-monitoring of the INR (+0.19) and full
self-management (+0.32). Distress ()0.44), perceived daily
hassles ()0.31) and strain on the social network ()0.21) were
reduced through full self-management. Improved patient
education was associated with increased distress (+0.33) and
perceived daily hassles (+0.23). Comparison at 26 weeks
between groups showed similar improvements on these out-
comes for self-monitoring and self-management vs. routine care
after education.
Keywords: oral anticoagulation, quality of life, self-manage-
ment
Introduction
Oral anticoagulant therapy (OAT) with coumarin drugs is of
vital importance in the prophylaxis and treatment of throm-
bosis. The efﬁcacy and relative safety of oral anticoagulants
have been proven extensively by clinical studies and different
therapeutic International Normalized Ratio (INR) target
ranges have been set for OAT in various indications [1]. Strict
control of the INR within the target INR range is required to
ensure good efﬁcacy of treatment, minimizing the rate of
thrombotic and bleeding complications. Due to the many
factors that inﬂuence OAT, frequent INR measurements and
dose adjustments are necessary.
In the Netherlands a national network of specialized
anticoagulation clinics is responsible for the management of
OAT [2]. These anticoagulation clinics collect blood samples,
perform the prothrombin time (PT)/INR measurements,
gather information on intercurrent diseases and co-medication,
establish the dosage of theOAT and provide advice for patients
and other physicians. The development of these specialized
anticoagulation clinics has led to improved management of
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OAT [2]. Frequent monitoring of the PT/INR values, however,
continues to be an important aspect of treatment, which may
have physical, psychological, social and ﬁnancial consequences
for both patient and the healthcare system. This need for
frequent monitoring may interfere with patients’ social and
working life, in addition to the possible stress caused by the
treatment itself and the condition necessitating this treatment.
The development of hand-held PT/INR measurement
devices, which determine the prothrombin time from capillary
whole blood, has led to the development of self-management
of OAT (self-measurement of INR values and self-dosing of
coumarin medication) by patients. The potential advantages of
patient self-management include improved convenience for
patients, with less interference with their lifestyle, better
compliance andmore frequent monitoring, as well as improved
quality of OAT resulting in less thromboembolic and hem-
orrhagic complications [3]. Improvement of the quality of
anticoagulant care through patient self-management has been
suggested by several studies comparing this new treatment
modality with the existing system, be it anticoagulant care
through a diversity of physicians [4–11] (general practitioners,
medical specialists, laboratory physicians) or through special-
ized anticoagulation clinics as in the Netherlands [12,13]. In
these studies the number of INR checks within the target range
and/or the estimated time that the INR fell within this range
was increased through patient self-management.
In recent years Quality of Life (QoL) has become an
important concept in medical care, linking clinical variables
with health-related quality of life [14]. Quality of life encom-
passes the effects of an illness and its treatment on the patient,
as perceived by the patient. Self-management of (chronic)
illness represents a major new development in medical care.
Beneﬁts of self-management on quality of life have been shown
in, for example, asthma [15] and diabetes mellitus [16,17].
Sawicki et al. noted an improvement in several treatment-
related areas of quality of life through patient self-manage-
ment in comparison with routine anticoagulant care through
family physicians [4]. Quality of life was assessed at baseline
and at end of study with the aid of a quality of life
questionnaire that the authors developed. Cromheeke et al.
used the same questionnaire in a study in the Netherlands
comparing anticoagulant care through specialized anticoag-
ulation clinics with patient self-management in a cross-over
study and also noted an improvement in treatment-related
quality of life [12], indicated by an increase in general
treatment satisfaction and a decrease in perceived daily
hassles and distress. Kulinna et al. found an improvement in
treatment quality and quality of life through self-monitoring
of the INR (no full self-management) [13]. They did not use
the Sawicki questionnaire. Independence and better organ-
ization of vacation and spare time were the most frequently
mentioned advantages of the new method.
Our study aimed to assess the effects on oral anticoagulant
treatment-related quality of life through different treatment
modalities: routine anticoagulant care through specialized
anticoagulation clinics; self-monitoring of the INR by the
patients but dosing by specialized anticoagulation clinics;
and full self-management of the OAT by patients. Because
self-management, by deﬁnition, includes extensive patient
education about their condition and its treatment, which may
affect quality of life rather than the self-management itself, we
also investigated the effect of increased patient education on
patient QoL. Previously, we reported the results concerning the
number of INR checks and the time in target INR range in this
randomized controlled trial, comparing patient self-manage-
ment of oral anticoagulant therapy with routine care delivered
by specialized anticoagulation clinics in the Netherlands [14].
Materials and methods
Patients
In this study performed by two Dutch anticoagulation clinics
which together are responsible for the oral anticoagulant
treatment of around 18 000 patients per year, patients were
selected by computer on the basis of the following criteria:
indication for long-term oral anticoagulant therapy with
phenprocoumon or acenocoumarol, at least 3 months of
OAT experience, and an age range of 18–75 years. The two
anticoagulation clinics represent different patient populations.
The Leiden anticoagulation clinic is in the west of the
Netherlands and essentially represents an urban environment,
while the Oost-Gelderland anticoagulation clinic is located in
the east of the country in a predominantly rural area.
Patients who were willing to participate in the study were
invited to three training sessions. After successful training the
patients were randomized into three treatment groups: weekly
self-measurement of the INR (group A); weekly self-meas-
urement of the INR and self-management of the OAT (group
B); or routine care in educated patients (group C). All patients
included in the study groups were followed for 26 weeks. A
schematic overview of the study design and ﬁnal patient
numbers is given in Fig. 1. In total 720 patients were contacted
for participation in training, of whom 184 consented to
participate, but of these four patients were later unavailable.
The quality of life studywas carried out within the conﬁnes of a
larger study looking at the quality of anticaogulant treatment.
In this study a large control group (group D) was included in a
Zelen design, as can be seen in Fig. 1.
A quality of life questionnaire was distributed to all patients
invited to the training sessions (n ¼ 180) at the start of the ﬁrst
training session, and again at the end of the follow-up
(26 weeks). The questionnaire at baseline was intended to
measure patient concerns under the routine anticoagulant care
system managed by the anticoagulation clinics, while the
(identical) end-of-study questionnaire was meant to measure
the impact of self-monitoring of the INR, full patient self-
management of OAT, and possibly of increased patient
education (see Quality of life questionnaire).
The structured training program consisted of three weekly
sessions of 90–120 min in which the patients received infor-
mation about the coagulation system and oral anticoagulant
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treatment and the inﬂuences thereon, were trained in working
with the CoaguChek device, and were instructed on
self-dosing of oral anticoagulant therapy with phenprocoumon
and acenocoumarol. Training was done by specialized teams
present in both anticoagulation clinics, consisting of physicians
and nurses, in groups of four to ﬁve patients.
Treatment modalities
In this study the effects on quality of life of different treatment
modalities were assessed.
Self-monitoring of the INR (group A) After going through
the training program the patients performed the measurement
of the INR at home on a weekly basis with the aid of a hand-
held coagulometer (CoaguChek; Roche Diagnostics,
Mannheim, Germany) and relayed the result together with
relevant information to the anticoagulation clinics. Dosing of
the OAT was done by physicians at the anticoagulation clinic
based upon the INR value and the relayed information; the
next day the patients received a new dosing schedule for their
anticoagulant medication by mail.
Patient self-management of OAT (group B) After going
through the training program the patients performed the
measurement of the INR at home on a weekly basis with the
aid of a hand-held coagulometer (CoaguChek; Roche
Diagnostics) and were themselves responsible for the dosing
of the anticoagulant medication. During the follow-up of the
study the INR results and dosing schedules were relayed to
the anticoagulation clinics as a safety measure. Corrections
were proposed by the anticoagulation clinics in case of clear
mistakes.
Increased patient education in routine care (group C) A
group of patients were randomized to return to routine
care after having received the training for self-management
of OAT. In the existing routine care system the patients
No of patients selected by computer
(n=916)
Patients ineligible
(n=35)
Randomisation
(n=881)
Group D: Routine Care
(n=161)
No of Patients
approached (n=720)
Patients
unavailble (n=4) or who
refused (n=536)
Training (3 sessions)
(n=180)
Patients withdrawn
or uneligible
(n=21)
Group B : weekly self-
measurement and self-
management (n=47)
Group A : weekly self-
measurement
(n=52)
Gourp C : Routine Care
(trained patients)
(n=60)
Fig. 1. Design and patient numbers involved in the study comparing patient self-management of oral anticoagulant therapy with routine anticoagulant
care delivered by specialized anticoagulation clinics. The area within the dotted line denotes the limits of the quality of life study.
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come to the specialized anticoagulation clinics, at intervals
determined by the stability of their INR values, where they
are seen by skilled nurses and a venepuncture is performed.
Dosing of the OAT is done by physicians based upon the
INR value, the dosage history and information about
changes in medication, illness, bleeding complications and
other relevant information. New dosing schedules are
forwarded to the patients by post (next-day delivery).
Quality of life questionnaire
The questionnaire used in the assessment of quality of life was
developed by Sawicki and coworkers in patients receiving oral
anticoagulation, and validated in their multicenter study
comparing patient self-management with conventional antico-
agulant care in Germany [4]. In Germany anticoagulant
therapy is conventionally managed by general practitioners.
The questionnaire was developed using the clinical impact
method in which items are selected from a larger pool of
statements based upon the importance given to them by the
patients [18]. The resulting questionnaire mirrored the most
important concerns of the patients regarding the deﬁned
condition or treatment.
The questionnaire consisted of 32 items covering ﬁve
treatment-related topics: general treatment satisfaction, self-
efﬁcacy, strained social network, daily hassles, and distress.
Self-efﬁcacy pertains to the patient’s belief in being able to
perform self-care activities. In modern clinical health psychol-
ogy self-efﬁcacy has been shown to predict preventive health
behavior and illness behavior [19]. Daily hassles are minor
stressful events that add to the burden of having to cope with a
chronic medical condition. Patients had to grade the degree to
which the different statements were applicable to their individ-
ual situation, with aminimum score of 1 (total disagreement) to
a maximum score of 6 (total agreement). Groups of individual
statements were combined into ﬁve topics, leading to a mean
score from 1 to 6 for the different topics. Improved quality of
life was indicated by rising scores for the topics of self-efﬁcacy
and general treatment satisfaction, and by diminishing scores
for the topics of daily hassles, distress, and strains on the social
network.
The questionnaire was translated from German into Dutch
and marginally adapted where necessary to make it compatible
to the situation in the Netherlands where anticoagulant care is
routinely handled by specialized anticoagulation clinics. The
structure of the original questionnaire was preserved, and the
questions were listed in the same order. Independently of our
study the same questionnaire, but another translation, has been
used and validated in another study assessing the quality of life
and therapeutic quality of patient self-management of oral
anticoagulation in the Dutch situation [12].
Statistical analysis
Results are presented as mean scores per treatment-related
topic with standard deviations (SD). We compared results at
26 weeks with baseline, as well as between groups at 26 weeks.
Paired samples t-test was used to compare scores between
baseline and end of study within the same patient group.
Independent samples t-test was used to compare between
different patient groups. Cronbach a was calculated to give an
indication of internal reliability of the ﬁve dimensions of the
questionnaire.
Results
One hundred and sixty three patients returned the question-
naire at baseline, and 118 patients returned the questionnaire at
the end of the study. One hundred and sixteen patients returned
both the baseline questionnaire and the end-of-study question-
naire: 47 patients who performed weekly INR measurements
with the CoaguChek device, 41 patients on patient self-
management of OAT, and 28 patients in the routine care in
educated patients group. All analyses are restricted to patients
who provided information at baseline and at 26 weeks. Patient
characteristics are shown in Table 1.
At baseline the QoL questionnaire provided a picture of
the concerns of the patients under the routine care system
(Table 2). Cronbach a values varied from 0.53 to 0.74
depending on the topic. The quality of life scores are given
on a scale of 1–6. The system of specialized anticoagulation
clinics seems to result in a high general treatment satisfaction
(score ¼ 5.11, SD ¼ 0.91) while giving rise to a moderate
degree of daily hassles (score ¼ 1.71, SD ¼ 0.64), distress
(score ¼ 2.05, SD ¼ 0.81) and straining of the social network
(score ¼ 1.46, SD ¼ 0.62). No differences were found
between the two participating anticoagulation clinics. There
were no striking differences between the sexes, although
women had a higher score for distress than men (d ¼ 0.31,
P ¼ 0.04). Daily hassles were scored higher by younger age
groups, especially below the age of 50 (d ¼+0.24, P ¼ 0.04),
as was the element of distress (d ¼+0.34, P ¼ 0.02), which
below the age of 40 increased even further (d ¼+0.70,
P ¼ 0.001).
At the end of the study increased patient education without
self-management (group C) resulted in a trend towards a slight
decrease in general treatment satisfaction, and in an increase in
distress (d ¼+0.33,P ¼ 0.03) and strain on the social network
(d ¼+0.21, P ¼ 0.02) (Table 3).
The patients who monitored their INR values at home
without self-dosing (group A) registered a trend towards an
increase in their general treatment satisfaction (d ¼ +0.19,
P ¼ 0.10) and an expected increase in their feeling of self-
efﬁcacy (d ¼+0.31, P < 0.01). There was little movement
against baseline in the other treatment-related topics registered
(Table 4).
The most important changes were seen in full patient self-
management of the OAT (group B). This mode of treatment
led to a clear increase (d ¼+0.49, P ¼ 0.01) in general
treatment satisfaction (score¼ 5.55, SD ¼ 0.63) and the feeling
of self-efﬁcacy (d ¼+0.32, P ¼ 0.014), and a signiﬁcant
decrease in the perception of daily hassles (d ¼ )0.31,
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P < 0.01) and distress (d ¼ )0.44, P < 0.001), while there
was evidence of less strain on the social network (d ¼ )0.21,
P ¼ 0.07) (Table 5).
When, rather than comparing the scores before and after the
trial, we compared between groups, we saw very similar results,
i.e. reduction in daily hassles, distress and strains in social
network, and increase in self-efﬁcacy and general satisfaction
for the self-monitoring and self-managing patients compared
with those who had received routine care. Although differences
between groups A and B were small, there was a trend towards
a further increase in general satisfaction by allowing the
patients full self-management (d ¼+0.30, P ¼ 0.14), and
Table 2 Routine care system: outcome of the quality of life questionnaire at baseline, concerning ﬁve treatment related topics, based on 32 items
All patients (n ¼ 163)
mean (SD)
Leiden anticoagulation
clinic (n ¼ 71)
mean (SD)
Oost-Gelderland
anticoagulation clinic (n ¼ 92)
mean (SD)
Daily hassles 1.71 (0.64) 1.62 (0.63) 1.78 (0.64)
Self-eﬃcacy 5.03 (0.88) 5.04 (0.83) 5.02 (0.93)
General treatment satisfaction 5.11 (0.91) 5.09 (0.90) 5.12 (0.93)
Distress 2.05 (0.81) 2.17 (0.87) 1.95 (0.76)
Strained social network 1.46 (0.62) 1.53 (0.60) 1.42 (0.63)
Minimum score ¼ 1, maximum score ¼ 6. The results are given for all patients and stratiﬁed for the diﬀerent anticoagulation clinics.
Table 3 Eﬀect of increased patient education (group C)
Baseline (n ¼ 28)
mean (SD)
Routine care system after
increased patient education (n ¼ 28)
mean (SD)
Diﬀerence against baseline
mean (P)*
Daily hassles 1.71 (0.54) 1.94 (0.67) +0.23 (P ¼ 0.117)
Self-eﬃcacy 5.05 (0.82) 5.07 (0.84) +0.02 (P ¼ 0.94)
General treatment satisfaction 5.13 (0.85) 4.90 (0.89) ) 0.23 (P ¼ 0.21)
Distress 1.95 (0.70) 2.29 (1.05) +0.33 (P ¼ 0.03)
Strained social network 1.44 (0.49) 1.65 (0.69) +0.21 (P ¼ 0.02)
Outcome of the questionnaire concerning ﬁve treatment-related topics, at baseline and at the end of the study period. Baseline score reﬂects the
conventional system of oral anticoagulant care through specialized anticoagulation clinics. Minimum score ¼ 1, maximum score ¼ 6. *Paired
samples t-test on the 28 patients with both baseline and end-of-study questionnaire available.
Table 1 Patient characteristics
Baseline
(n ¼ 163)
Group A:
self-measurement
(n ¼ 47)*
Group B:
self-management
(n ¼ 41)*
Group C: increased
patient education
(n ¼ 28)*
Age in years (range) 58.1 (21–75) 54.8 (24–75) 53.9 (24–75) 59.8 (21–73)
Male/female ratio 115/37 38/9 31/10 20/8
Indication for anticoagulation
DVT/PE/venousTE 43 (26.4%) 11 (23.4%) 14 (34.2%) 7 (25.0%)
Arterial TE 4 (2.5%) 1 (2.1%) 1 (2.4%) 1 (3.6%)
Atrial ﬁbrillation 26 (15.9%) 5 (10.6%) 7 (17.1%) 5 (17.9%)
Artiﬁcial heart valves 34 (20.9%) 12 (25.5%) 5 (12.2%) 6 (21.4%)
Cardiovascular prophylaxis 34 (20.9%) 12 (25.5%) 8 (19.5%) 5 (17.9%)
Cerebrovascular prophylaxis 2 (1.2%) – 1 (2.4%) –
Vascular prosthesis 15 (9.2%) 4 (8.5%) 3 (7.3%) 4 (14.3%)
Thrombophilia 5 (3.1%) 2 (4.3%) 2 (4.9%) –
Anticoagulant
Fenprocoumon 119 (73.0%) 30 (63.8%) 26 (63.4%) 23 (82.1%)
Acenocoumarol 44 (27.0%) 17 (36.2%) 15 (36.6%) 5 (17.9%)
Target INR
2.5–3.5 78 (47.9%) 22 (46.8%) 26 (63.4%) 10 (35.7%)
3.0–4.0 85 (52.1%) 25 (53.2%) 15 (36.6%) 18 (54.3%)
Quality of treatment
% INR checks in range (95% CI) 58.7 (55.0, 62.4) 63.9 (59.8, 68.0) 66.3 (61.0, 71.5) 61.3 (55.4, 67.1)
% time in range (95% CI) 63.5 (59.7, 67.3) 66.9 (62.7, 71.0) 68.6 (63.7, 73.6) 67.9 (62.9, 73.0)
*Patients who returned the questionnaire both at baseline and at end of study. From previously published quality of treatment analysis [14].
DVT, Deep vein thrombosis; PE, pulmonary embolism; TE, thromboembolism.
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especially a further signiﬁcant decrease in the feelings of distress
(d ¼ )0.50, P < 0.001).
Discussion
Two major beneﬁts from patient self-management of oral
anticoagulant therapy have been put forward: an improvement
in the quality of the therapy resulting in fewer complications,
andan improvement in thequalityof life through less imposition
by regular blood sampling on the patients’ way of life. It is
evident fromour study that patient self-management in the ﬁeld
of oral anticoagulant therapy does provide an improvement in
patientqualityof life comparedwithmanagementby specialized
anticoagulationclinics.This isborneoutbyan increasedsenseof
general treatment satisfaction and a diminished perception of
treatment-related distress or social strain.
From the baseline assessment it is also clear that overall the
general treatment satisfaction indicated by the patients in the
Dutch system of specialized anticoagulation clinics (score 5.11,
SD 0.91) is higher than in Germany, where anticoagulation
treatment is mostly done by family physicians (score 2.90, SD
1.38) [4], although this difference may also be attributable to
differences between patients in different countries. Younger
patients report less general treatment satisfaction than older
patients, which may be explained by the higher degree of
intrusion into their lifestyle by the frequent blood sampling
than is the case in older patients. From the discussions we had
with patients it is clear that younger patients experience more
problems in their professional (time off work through frequent
visits to the anticoagulation clinics) and social lives caused by
the frequent visits to anticoagulation clinics, and think
themselves more restricted in their vacation plans. Younger
patients also show a higher degree of irritation with daily
hassles caused by the treatment, showing a need to compromise
between the perceived potential side-effects of anticoagulant
treatment and an active lifestyle. Over all age groups the
perception of distress is more pronounced in women than in
men (P < 0.05), and seems slightly higher in urban areas than
in rural surroundings (P < 0.10), although this was not
statistically signiﬁcant.
In our study one group of patients underwent training for
self-management of OAT but was afterwards randomized to
continue with routine care to reﬂect the effect of increased
patient awareness. These patients tended to report lower
treatment satisfaction at the end of the study, which may be
explained by the fact that they had agreed to participate in the
study primarily in the hope of being randomized for self-
management and, being denied this opportunity, were then
even less satisﬁed with the existing care system than they were
beforehand. More signiﬁcantly, they expressed a higher degree
of distress and an increased strain on their social network after
having received information about the treatment’s effects,
complications and inﬂuences thereon. We saw positive effects
on QoL when we compared between groups, using this routine
care group as a reference. Although this analysis is generally
perceived as methodologically stronger than a before–after
comparison, since it rules out regression-to-the-mean effects, it
should be borne in mind that the end-of-study questionnaire
results in those who were trained for self-management but
subsequently received routine care may be heavily inﬂuenced
Table 4 Eﬀect of patient self-monitoring of the International Normalized Ratio (INR) (group A)
Baseline (n ¼ 47)
mean (SD)
Patient self-monitoring
of the INR (group A) (n ¼ 47)
mean (SD)
Diﬀerence against
baseline (routine care) (n ¼ 47)
mean (P)*
Daily hassles 1.61 (0.57) 1.52 (0.50) )0.09 (P ¼ 0.31)
Self-eﬃcacy 4.98 (0.82) 5.28 (0.68) +0.31 (P < 0.01)
General treatment satisfaction 5.11 (0.82) 5.30 (0.71) +0.19 (P ¼ 0.10)
Distress 1.99 (0.75) 2.05 (0.78) +0.06 (P ¼ 0.56)
Strained social network 1.44 (0.55) 1.42 (0.50) )0.02 (P ¼ 0.82)
Outcome of the questionnaire concerning ﬁve treatment-related topics. End-of-study evaluation of self-measurement group against baseline
(conventional system of oral anticoagulant care through specialized anticoagulation clinics). Minimum score ¼ 1, maximum score ¼ 6. *Paired
samples t-test on the 47 patients with both baseline and end-of-study questionnaire available.
Table 5 Eﬀect of full patient self-management (group B)
Baseline (n ¼ 41)
mean (SD)
Patient self-management
(Group B) (n ¼ 41)
mean (SD)
Diﬀerence against
baseline (routine care) (n ¼ 41)
mean (P)*
Daily hassles 1.79 (0.74) 1.48 (0.52) )0.31 (P < 0.01)
Self-eﬃcacy 5.20 (0.76) 5.52 (0.72) +0.32 (P ¼ 0.01)
General treatment satisfaction 5.06 (1.02) 5.55 (0.63) +0.49 (P ¼ 0.01)
Distress 2.16 (0.79) 1.72 (0.59) )0.44 (P < 0.001)
Strained social network 1.55 (0.81) 1.34 (0.39) )0.21 (P ¼ 0.07)
Outcome of the questionnaire concerning ﬁve treatment-related topics, based on 32 items. End-of-study evaluation of self-management group
against baseline (conventional system of oral anticoagulant care through specialized anticoagulation clinics). Minimum score ¼ 1, maximum
score ¼ 6. *Paired samples t-test on the 47 patients with both baseline and end-of-study questionnaire available.
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by feelings of dissatisfaction with the study process, i.e. being
denied self-management. Increased patient education may
serve to improve the medical quality of the OAT, as we have
seen in the part of the study dealing with this endpoint. In this
group of patients time in INR target range was increased by
almost 5% [14], but perhaps at the cost of more distress and
anxiety for the patient.
Giving the patients the opportunity to measure their own
INR values at home relieves them from the burden of frequent
visits to the anticoagulation clinics. In this patient group we
noted an increase in general treatment satisfaction and the
feeling of self-efﬁcacy. There was little change in the perception
of daily hassles, distress or strain on the social network against
baseline; the increases that were noted in patients who also
completed the training program but went back to the routine
care system were not registered in these patients. Evidently,
having the possibility to check the INR whenever they thought
it necessary and the fact that they had some role in the
treatment, compensated for the increased distress and anxiety
caused by the increased patient awareness.
The largest changes in the scores of the ﬁve treatment-related
topics were seen in the group of patients who were randomized
for full self-management under supervision of the anticoagu-
lation clinics. There was a clear increase in general treatment
satisfaction and feeling of self-efﬁcacy and—in contrast to the
patients limited to self-monitoring—clear decreases in the
perception of daily hassles, distress and strain on the social
network. Having both the opportunity of INR measurements
whenever necessary and the knowledge to adjust their medi-
cation seems to improve the conﬁdence of the patients to deal
with the different facets of their treatment. It has to be stressed
that patients could rely on the services of the anticoagulation
clinics at any time in case of problems or need for advice. In the
part of the study dealing with the medical quality of the OAT,
this group of patients also scored best as to the percentage of
time within the INR target range [14].
The questionnaire used to evaluate the perceived quality of
life of the patients has some drawbacks, but as it has been used
by the few authors who have ventured into this terrain, it offers
the possibility of making comparisons with earlier work. One
of the weaknesses of the questionnaire is shown by the
relatively low Cronbach a values (0.53–0.74), although both
Sawicki et al. [4] and Cromheecke et al. [12], using the same
questionnaire, reported somewhat higher Cronbach a values
(0.64–0.82 and 0.70–0.83, respectively).
From this study it is clear that patient self-management of
oral anticoagulant therapy in motivated patients improves
general treatment satisfaction, and decreases patients’ percep-
tion of treatment-related daily hassles, distress and strain on
their social network. The opportunity for home measurement
of the INR also increases general treatment satisfaction but
does not lessen the emotional impact of the treatment in the
same way. Patient self-management of the oral anticoagulant
therapy seems to offer the best treatment modality for
motivated patients. This result is in line with recent research
on self-management in other chronic medical conditions
demonstrating the importance of involving patients in the care
of their afﬂiction [20,21]. However, it remains unclear whether
self-management is an option for large numbers of patients, as
we found only a minority of patients prepared to enter the
study.
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